SCHEMBL27740422

SCHEMBL27740422

Cc1nc(-c2cccc([N+](=O)[O-])c2)n(OC(=O)C(C)(C)C)c1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
PKM P14618 2/20 0.57
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
AMY1A P0DUB6 1/20 0.41
TSHR P16473 1/20 0.40
ACHE P22303 1/20 0.40
MAPT P10636 7/20 0.40
RAB9A P51151 5/20 0.40
TDP1 Q9NUW8 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NPC1 O15118 2/20 0.40
THRB P10828 2/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
RECQL P46063 1/20 0.40
PTGS2 P35354 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606178 0.77 ALDH1A1 (0.57) ALDH1A1PKMMEN1KMT2AAMY1A
SCHEMBL4606694 0.76 ALDH1A1 (0.60) ALDH1A1PKMMEN1KMT2AAMY1A
SCHEMBL4027884 0.69 ALDH1A1 (0.44) ALDH1A1PKMMEN1KMT2AMAPT
SCHEMBL6960006 0.69 ALDH1A1 (0.54) ALDH1A1PKMMEN1KMT2ATSHR
SCHEMBL6960011 0.69 ALDH1A1 (0.54) ALDH1A1PKMMEN1KMT2ATSHR
SCHEMBL10746185 0.69 ALDH1A1 (0.70) ALDH1A1PKMMEN1KMT2AACHE
SCHEMBL11200693 0.68 ALDH1A1 (0.52) ALDH1A1PKMMEN1KMT2ATSHR
SCHEMBL10925033 0.68 ALDH1A1 (0.50) ALDH1A1PKMMEN1KMT2AMAPT
SCHEMBL10924766 0.67 ALDH1A1 (0.54) ALDH1A1PKMMEN1KMT2AMAPT
SCHEMBL8824809 0.67 ALDH1A1 (0.49) ALDH1A1PKMMEN1KMT2AAMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101296911-A Arylurea derivatives as modulators of chemokine receptor activity NOVARTIS AG (CH) 2008-10-29 CN disclosed